VENUSREM.BO

Venus Remedies Limited VENUSREM.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VENUSREM.BO KILITCH.BO KILITCH.NS INDSWFTLAB.NS INDSWFTLAB.BO MEDICAMEQ.BO MEDICAMEQ.NS ALBERTDAVD.NS JENBURPH.BO SGRL.BO
6M 42.44 % -25.61 % -24.65 % 3.54 % 3.80 % -9.09 % -9.58 % -23.81 % -14.98 % -27.49 %
YTD 3.77 % -5.88 % -5.61 % 22.61 % 22.90 % -1.30 % -2.08 % -4.70 % 0.91 % -2.19 %
1Y 161.99 % 2.36 % 2.43 % 4.03 % 2.22 % -21.62 % -21.66 % -42.04 % -10.62 % -37.01 %
3Y 96.20 % 116.99 % 118.06 % 70.96 % 22.48 % -54.39 % -54.82 % 25.94 % 70.65 % 71.63 %
5Y 96.20 % 259.69 % 262.97 % 55.83 % 22.48 % -15.17 % -32.32 % 58.87 % 167.69 % 169.73 %
10Y 96.20 % 760.51 % 755.49 % 192.36 % 22.48 % 516.69 % -32.32 % 125.70 % 196.08 % 1 325.97 %
From the beginning 96.20 % 14 272.34 % 167.61 % 438.59 % 22.48 % 4 966.89 % -32.32 % 125.70 % 13 962.03 % 1 325.97 %

Dividend

Venus Remedies Limited

Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited

Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited

Medicamen Biotech Limited

Medicamen Biotech Limited

Albert David Limited

Jenburkt Pharmaceuticals Limited

Shree Ganesh Remedies Limited